Identified a determinant protein for tumor progression and metastasis in Rhabdomyos

(IDIBELL-Bellvitge Biomedical Research Institute) LOXL2 increases the metastatic capacity of tumors from Rhabdomyoarcoma, a childhood cancer. The metastasic activity of LOXL2 is inside the cells and is independent of its classical function.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news